Cloning, expression, purification and expression condition optimization of a-enolase from Staphylococcus aureus in Escherichia coli

Minerva Biotecnologica

Volumn 28, Issue 1, 2016, Pages 33-38

  Ghasemi, Younes ^a,c,d   Hajighahramani, Nasim ^a,b,c   Dabbagh, Fatemeh ^a,c   Ghoshoon, Mohammad B ^a,c   Yarahmadi, Elham ^b,c   Mobasher, Mohammad A ^c,e   Zeri Najafabady, Nima Monta ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cloning; ENO1 protein; Escherichia coli; Human; Molecular; Staphylococcus aureus; Vaccines

Indexed keywords

ALPHA ENOLASE; MEMBRANE ANTIGEN; RECOMBINANT ENZYME; RECOMBINANT PROTEIN;

ARTICLE; BIOTECHNOLOGICAL PROCEDURES; ENZYME PURIFICATION; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE EXPRESSION; GENE INDUCTION; GENE INSERTION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

EID: 84962588809     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Pancholi V. Multifunctional a-enolase: Its role in diseases. Cell Mol Life Sci 2001;58: 902-20.
2. L iu KJ, Shih NY. The role of enolase in tissue invasion and metastasis of pathogens and tumor cells. J Cancer Mol 2007;3: 45-8.
3. G hosh AK, Jacobs-Lorena M. Surface-expressed enolases of plasmodium and other pathogens. Mem Inst Oswaldo Cruz 2011;106: 85-90.
4. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: Identification of alpha-enolase as a candidate plasminogen receptor. Biochem 1991;30: 1682-91.
5. Pancholi V, Fischetti VA. Alpha-enolase, a novel strong plasmin (ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem 1998;273: 14503-15.
6. L opes J, Dos Reis M, Brentani R. Presence of laminin receptors in Staphylococcus aureus. Science 1985;229: 275-7.
7. Switalski L, Speziale P, Höök M, Wadström T, Timpl R. Binding of Streptococcus pyogenes to laminin. J Biol Chem 1984;259: 3734-8.
8. Mota G, Carneiro C, Gomes L, Lopes J. Monoclonal antibodies to Staphylococcus aureus laminin-binding proteins cross-react with mammalian cells. Infect Immun 1988;56: 1580-4.
9. Moscato S, Pratesi F, Sabbatini A, Chimenti D, Scavuzzo M, Passantino R, et al. Surface expression of a glycolytic enzyme, a-enolase, recognized by autoantibodies in connective tissue disorders. Eur J Immunol 2000;30: 3575-84.
10. R edlitz A, Fowler BJ, Plow EF, Miles LA. The role of an enolaserelated molecule in plasminogen binding to cells. Eur J Biochem 1995;227: 407-15.
11. Derbise A, Song YP, Parikh S, Fischetti VA, Pancholi V. Role of the C-terminal lysine residues of streptococcal surface enolase in Gluand Lys-plasminogen-binding activities of group A streptococci. Infect Immun 2004;72: 94-105.
12. C arneiro CRW, Postol E, Nomizo R, Reis LFL, Brentani RR. Identification of enolase as a laminin-binding protein on the surface of Staphylococcus aureus. Microb Infect 2004;6: 604-8.
13. L owy FD. Antimicrobial resistance: The example of Staphylococcus aureus. J Clin Invest 2003;111: 1265-73.
14. C osgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillinresistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003;36: 53-9.
15. Hutchison CA, Peterson SN, Gill SR, Cline RT , White O, Fraser CM, et al. Global transposon mutagenesis and a minimal Mycoplasma genome. Science 1999;286: 2165-9.
16. Glowalla E, Tosetti B, Krönke M, Krut O. Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus. Infect Immun 2009;77: 2719-29.
17. T errier B, Degand N, Guilpain P, Servettaz A, Guillevin L, Mouthon L. Alpha-enolase: A target of antibodies in infectious and autoimmune diseases. Autoimmun Rev 2007;6: 176-82.
18. Zhang A, Chen B, Mu X, Li R, Zheng P, Zhao Y, et al. Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2. Vaccine 2009;27: 1348-53.
19. Spellberg B, Daum R. Development of a vaccine against Staphylococcus aureus. Semin Immunopathol 2012;34: 335-48.
20. G arcía-Lara J, Foster SJ. Anti-Staphylococcus aureus immunotherapy: Current status and prospects. Curr Opin Pharmacol 2009;9: 552-7.
21. Ghasemi Y, Dabbagh F, Ghasemian A. Cloning of fibrinolytic enzyme (subtilisin) gene from Basillus subtilis in Escherichia coli. Mol Biotechnol 2012;52: 1-7.
22. Zhang H, Wang Y, Hu X, Zhu H, Wei Z. Effect of different culture conditions for dextransucrase production in Escherichia coli using lactose as inducer. Afr J Biotechnol 2009;8: 1577-82.
23. Howhan P, Pornbanlualap S. Cloning and effective induction of Escherichia coli nucleoside diphosphate kinase by lactose. ScienceAsia 2003;29: 347-53.
24. Weng YP, Hsu FC, Yang WS, Chen HP. Optimization of the overexpression of glutamate mutase S component under the control of T7 system by using lactose and IPTG as the inducers. Enzyme Microb Technol 2006;38: 465-9.
25. G ombert AK, Kilikian BV. Recombinant gene expression in Escherichia coli cultivation using lactose as inducer. J Biotechnol 1998;60: 47-54.
26. Peacock SJ, de Silva I, Lowy FD. What determines nasal carriage of Staphylococcus aureus. Trends Microbiol 2001;9: 605-10.
27. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 2008;29: 996-1011.
28. McCaig LF, McDonald LC, Mandal S, Jernigan DB. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis 2006;12: 1715-23.
29. Nagy G, Emody L, Pál T. Strategies for the development of vaccines conferring broad-spectrum protection. Int J Med Microbiol 2008;298: 379-95.
30. Projan SJ, Nesin M, Dunman PM. Staphylococcal vaccines and immunotherapy: To dream the impossible dream? Curr Opin Pharmacol 2006;6: 473-9.
31. Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. P Natl Acad Sci 2006;103: 16942-7.